CurrentUnitedHealthcarePolicy CS080NE.P

Motorized Spinal Traction (for Nebraska Only)

Policy governing the medical necessity and coverage of motorized spinal traction (vertebral axial decompression) for treating neck and low back disorders in Nebraska; applies to providers and UnitedHealthcare benefit determinations in that state.

Policy Summary

PayerUnitedHealthcare

PolicyMotorized Spinal Traction (for Nebraska Only)

Policy CodePolicy CS080NE.P

Change TypeAdministrativestate-specific copy created

Effective DateJun 1, 2025

Next Review DateN/A

Key ActionDo not provide motorized spinal traction (vertebral axial decompression) as it is considered not medically necessary in Nebraska; check plan-specific prior authorization and benefit rules before delivering services.

SourceLink

POLICY UPDATE CHANGES

Supporting Information section (Clinical Evidence) updated to reflect the most current information.

Created state-specific policy version for the state of Nebraska (no change to coverage guidelines).

Nebraska-onlystate-specific applicability

S9090listed procedure code

Insufficient evidencecoverage rationale

32 RCTsCochrane trials

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Cochrane participants

Coverage Criteria and Rationale

Not Medically Necessary

Motorized spinal traction (vertebral axial decompression) is considered not medically necessary for treatment of neck and low back disorders when evaluated against available evidence.

Primary coverage stance: Motorized spinal traction devices are unproven and not medically necessary for treating neck and low back disorders due to insufficient evidence of efficacy.

Applies to Nebraska only per policy header.

Evidence-based coverage considerations

Coverage stance based on evidence and guideline conclusions in this document:

Primary evidence summary: High-quality systematic review and multiple randomized trials show traction (manual or mechanical) provides little or no difference versus placebo/sham/no treatment or other active therapies for low back pain outcomes (pain, function, global improvement, return to work).

Cochrane update (Wegner et al. 2013): 32 RCTs, 2,762 participants; overall low- to moderate-quality evidence; adverse events reported in some studies.

NSD and device-specific studies: Available evidence for motorized spinal decompression systems (e.g., DRX9000, VAX-D, IDD) consists largely of small RCTs, retrospective case series, and non-randomized studies with methodological limitations; results are inconsistent and insufficient to support efficacy claims.

Examples: DRX9000 case series (Apfel 2010; Macario 2008), IDD RCT (Schimmel 2009) showing no difference vs sham; VAX-D prospective case series (Beattie 2008)

Neck pain evidence: Evidence for vertebral axial decompression or motorized traction for neck pain is limited and consists mainly of case reports/series; well-designed RCTs are lacking.

NASS guidance recommends subgroup analyses and notes insufficient evidence for traction in cervical radiculopathy.

Guideline conclusions: Major clinical guidelines state evidence is insufficient to recommend traction: ACP (2017) found insufficient evidence for traction in acute, subacute, or chronic LBP; NASS (2011, 2020/2021) considers evidence insufficient to recommend traction for subacute or chronic LBP and for lumbar disc herniation with radiculopathy or spinal stenosis.

ACP 2017; NASS 2011, 2020/2021

This policy applies only to the State of Nebraska. Coverage determinations and applicability described in this document are specific to Nebraska and do not automatically extend to other states or programs.

The document does not list explicit procedure- or diagnosis-specific exclusions for motorized spinal traction; however, clinical evidence summaries and guideline conclusions cited herein indicate limited or insufficient evidence of effectiveness for traction modalities. Plans may therefore decline routine coverage absent plan-specific documentation or criteria supporting clinical benefit.

Motorized spinal traction therapies, including vertebral axial decompression systems, are considered unproven and not medically necessary for treating neck and low back disorders due to insufficient evidence of efficacy.

Evidence from systematic reviews, randomized controlled trials, and practice guidelines indicates that traction—whether manual or mechanical—provides little or no difference in key outcomes for non-specific low back pain (pain, function, global improvement, return to work). Overall evidence is low- to moderate-quality and insufficient to support routine use for acute, subacute, or chronic low back pain or for radiculopathy or spinal stenosis; therefore traction is considered not medically necessary when used routinely without stronger evidence or specific plan criteria.

Applicable Codes

Applicable Codes (reference only)HCPCS

S9090

Vertebral axial decompression, per session

Provider Actions, Prior Authorization, and Billing Notes

Denial Risk

Denial Risk for Motorized Spinal Traction

Motorized spinal traction (e.g., vertebral axial decompression) is considered unproven and not medically necessary for treatment of neck or low back disorders due to insufficient evidence of efficacy. Services using these devices are at risk for denial.

Affected code: S9090 — Vertebral axial decompression, per session
Denial risk: Prior authorization may be denied and claims may be declined as not medically necessary

Note

Coverage Governance and FDA Note

FDA regulation or clearance of powered traction equipment is informational only. FDA clearance does not alone establish coverage. Coverage determinations must follow applicable federal, state, and contractual benefit requirements.

FDA note: Refer to FDA resources for device listings (product code ITH); clearance does not guarantee coverage

Background and Evidence Summary

Vertebral axial decompression is a form of motorized spinal traction that uses a computer-driven table and a pelvic harness to apply controlled, cyclic distraction forces to the spine over a series of treatment cycles. Descriptions of these systems emphasize a series of traction sessions delivered by powered tables intended to unload or decompress intervertebral structures.

Trials, systematic reviews and case series

Supplementary evidence details from trials, systematic reviews, and observational series informing the evidence stance:

Cochrane-style systematic review details: Wegner et al. (2013) update included 32 RCTs (2,762 participants) and concluded traction has little or no impact on pain intensity, functional status, global improvement, or return to work for people with low back pain; evidence quality ranged from very low to moderate and adverse effects were reported in some studies.

Adverse effects in some trials included increased pain, aggravation of neurological signs, and subsequent surgery.

Small RCTs and negative device trial: Schimmel et al. (2009) RCT (60 patients) of IDD versus sham found improvements in both groups but no between-group differences, indicating no clear efficacy for the active IDD intervention compared with sham.

Definitions

Vertebral axial decompression — definition

DefinitionVertebral axial decompression is a type of motorized spinal traction that uses a computer-driven table and a pelvic harness to apply cyclic distraction forces to the spine; the table is slowly extended through a series of traction cycles where tension is gradually increased and then decreased.

Typical procedure elementsPatient lies on a specialized table, a pelvic harness is applied, and the table performs controlled extension and distraction over multiple cycles; number of sessions varies.

Therapeutic intentAims to reduce spinal loading and decompress intervertebral discs to relieve back or neck pain.

Non-surgical spinal decompression (NSD) — definition and evidence relation

DefinitionNon-surgical spinal decompression (NSD) refers to motorized traction modalities and computerized traction systems evaluated in trials and systematic reviews for low back pain with or without radiculopathy.

Policy Revision History

2025-11-01addedLatest

Created state-specific policy version for the state of Nebraska; no change to coverage guidelines.

2025-06-01revised

Updated the Clinical Evidence (Supporting Information) section; archived previous policy version CS080.O.

Policy Summary

PayerUnitedHealthcare

PolicyMotorized Spinal Traction (for Nebraska Only)

Policy CodePolicy CS080NE.P

Change TypeAdministrativestate-specific copy created

Effective DateJun 1, 2025

Next Review DateN/A

SourceLink

On This Page

Prior Authorization

Policy Use and Contractual Check

Before applying this policy, verify the member's specific federal, state, or contractual benefit terms, as those requirements govern and may differ from this standard policy.

Check plan-specific coverage and prior authorization requirements before rendering services
In event of conflict, federal/state/contractual requirements supersede this policy

Step Therapy

Step Therapy / Related Services

No specific step therapy is defined for motorized spinal traction in this policy. Related policies may apply and should be reviewed when considering alternative or adjunctive services.

Related policies to review: Home Traction Therapy (Nebraska Only); Mechanical Stretching Devices (Nebraska Only); Electromagnetic Therapy for Wounds (Nebraska Only)
If plan requires step therapy or conservative care trials, follow the member's plan-specific prior authorization and step-therapy rules

Outcomes assessed at 2, 6 and 14 weeks (VAS, ODI, SF-36).

Case series and observational reports: Retrospective and prospective case series (Apfel 2010: DRX9000, 30 patients; Macario 2008/2006 reviews; Beattie 2008: VAX-D, 296 patients) report symptom improvement but are limited by lack of control groups, potential bias, and inability to attribute causality.

Authors consistently call for randomized controlled trials to validate findings.

RCT comparing motorized traction with other modalities: Unlu et al. (2008) RCT comparing motorized traction, ultrasound, and low-power laser in 60 patients with lumbar disc herniation found similar improvements across treatment groups, with no clear superiority of motorized traction.

MRI and clinical outcomes measured at baseline, end of treatment, and at one and three months.

Evidence summarySystematic reviews and RCTs (including a Cochrane-style review of 32 RCTs, 2,762 participants) show low- to moderate-quality evidence that traction generally makes little or no difference versus placebo, sham, or other treatments for pain, function, global improvement, or return to work.

Clinical limitationsAvailable NSD studies include small RCTs, retrospective case series, and nonrandomized designs with methodological limitations and inconsistent results; high-quality randomized trials are needed.

Non-surgical spinal decompression — device examples and goals

Device examplesCommon motorized traction/NSD systems referenced in the literature include DRX9000, VAX-D, and IDD.

Representative study examplesVAX-D: prospective prone lumbar traction case series (Beattie et al. 2008; 296 patients); DRX9000: published case series and retrospective reports; IDD: RCT (Schimmel et al. 2009) and small trials reported in reviews.

Intended therapeutic goalThese devices aim to mechanically distract the spine to decompress intervertebral discs, restore disc height, and reduce discogenic pain, though efficacy remains unproven.